Alan W Dunton MD | Chief Medical Advisor & Non-Executive Director
Recce Pharmaceuticals
Based in the US, Dr. Dunton, as the Director of Palatin Technologies, brings a wealth of experience with over three decades in senior pharmaceutical roles. Notably, he served as the President and Managing Director of the Janssen Research Foundation (J&J Research). Dr. Dunton successfully advanced multiple blockbuster antibiotics through to commercialization at Fortune 500 companies, such as J&J and Roche, where he played instrumental roles in shaping the commercial success of pharmaceutical products. Dr. Dunton played a key role in the recent sale of Vylessi® to Cosette Pharmaceuticals for USD $12M, continuing his track record of fostering advancements in drug development and successful commercialization efforts.
Appearances:
Day 1 - World Antimicrobial Resistance Congress & Disease Prevention Control Summit 2024 @ 09:00
Keynote opening plenary: Never surrender: Mobilizing the global fight against antibiotic resistance
The keynote opening plenary, “Never surrender: Mobilizing the global fight against antibiotic resistance,” aims to pinpoint the tools necessary in combatting antimicrobial resistance worldwide, from new therapies to increased antibiotic stewardship. What is the ‘wake-up’ call experts – and communities – need? Experts from Recce Pharmaceuticals, based in Australia, and the American Society for Microbiology will be on site to discuss.
Sponsored by Recce Pharmaceuticals
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events